Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · IEX Real-Time Price · USD
0.148
-0.002 (-1.40%)
At close: Jul 19, 2024, 4:00 PM
0.158
+0.010 (6.42%)
Pre-market: Jul 22, 2024, 7:06 AM EDT
Zomedica Revenue
Zomedica had revenue of $25.97M in the twelve months ending March 31, 2024, with 25.68% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $6.26M with 14.23% year-over-year growth. In the year 2023, Zomedica had annual revenue of $25.19M with 33.05% growth.
Revenue (ttm)
$25.97M
Revenue Growth
+25.68%
P/S Ratio
5.59
Revenue / Employee
$180,319
Employees
144
Market Cap
145.03M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 25.19M | 6.26M | 33.05% |
Dec 31, 2022 | 18.93M | 14.80M | 358.02% |
Dec 31, 2021 | 4.13M | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Quipt Home Medical | 185.39M |
InfuSystem Holdings | 127.41M |
Lifecore Biomedical | 103.27M |
Myomo | 19.55M |
ProQR Therapeutics | 14.66M |
ZOM News
- 5 days ago - The United States Eventing Association Names Zomedica's PulseVet(R) as the Official Shock Wave of the USEA - Accesswire
- 13 days ago - Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets - Accesswire
- 21 days ago - US Equestrian Names Zomedica's PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians - Accesswire
- 25 days ago - Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform - Accesswire
- 27 days ago - Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark - Accesswire
- 6 weeks ago - Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024 - Accesswire
- 6 weeks ago - Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference - Accesswire
- 6 weeks ago - Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels - Accesswire